Zhongjian Liu
No. 17, South Renmin Road
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A method based on 10B isotope tracer for seepage detection in salt lakes.
Journal: RSC advances
Published: April 21, 2025
BORIS variant SF2(C2/A4) promotes the malignant development of liver cancer by activating epithelial-mesenchymal transition and hepatic stellate cells.
Journal: Molecular carcinogenesis
Published: September 01, 2022
AMPKα2/HNF4A/BORIS/GLUT4 pathway promotes hepatocellular carcinoma cell invasion and metastasis in low glucose microenviroment.
Journal: Biochemical pharmacology
Published: June 15, 2022
Knockdown of CTCF reduces the binding of EZH2 and affects the methylation of the SOCS3 promoter in hepatocellular carcinoma.
Journal: The international journal of biochemistry & cell biology
Published: August 23, 2019
CAF-induced placental growth factor facilitates neoangiogenesis in hepatocellular carcinoma.
Journal: Acta biochimica et biophysica Sinica
Published: June 18, 2019
Detection of promoter methylation status of suppressor of cytokine signaling 3 (SOCS3) in tissue and plasma from Chinese patients with different hepatic diseases.
Journal: Clinical and experimental medicine
Published: March 22, 2017
Hypomethylation of BORIS is a promising prognostic biomarker in hepatocellular carcinoma.
Journal: Gene
Published: February 10, 2017
Nutrient deprivation-related OXPHOS/glycolysis interconversion via HIF-1α/C-MYC pathway in U251 cells.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: September 24, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026